Antral follicle count provides additive information to hormone measures for determining ovarian function in breast cancer survivors

被引:8
|
作者
Su, H. Irene [1 ]
Chung, Karine [2 ]
Sammel, Mary D. [3 ]
Gracia, Clarisa R. [3 ,4 ]
DeMichele, Angela [3 ,5 ]
机构
[1] Univ Calif San Diego, Moores Canc Ctr, Dept 0901, Div Reprod Endocrinol & Infertil, La Jolla, CA 92093 USA
[2] Univ So Calif, Div Reprod Endocrinol & Infertil, Los Angeles, CA USA
[3] Univ Penn, Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Div Reprod Endocrinol & Infertil, Philadelphia, PA 19104 USA
[5] Univ Penn, Sch Med, Rowan Breast Ctr, Abramson Canc Ctr, Philadelphia, PA 19104 USA
关键词
Breast cancer; antral follicle count; ovarian reserve; AMH; FSH; PREMENOPAUSAL WOMEN; YOUNG-WOMEN; RESERVE; CHEMOTHERAPY;
D O I
10.1016/j.fertnstert.2010.12.005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
In breast cancer survivors, antral follicle count appears to provide data on ovarian function that are independent of antimullerian hormone, FSH, and inhibin B. Therefore, ultrasound appears to be a tool that may not only corroborate, but also add to the accuracy of hormone measures for determining ovarian function in breast cancer survivors. (Fertil Steril (R) 2011;95:1857-9. (C)2011 by American Society for Reproductive Medicine.)
引用
收藏
页码:1857 / 1859
页数:3
相关论文
共 50 条
  • [1] Antimullerian Hormone and Inhibin B Are Hormone Measures of Ovarian Function in Late Reproductive-Aged Breast Cancer Survivors
    Su, H. Irene
    Sammel, Mary D.
    Green, Jamie
    Velders, Luke
    Stankiewicz, Corrie
    Matro, Jennifer
    Freeman, Ellen W.
    Gracia, Clarisa R.
    DeMichele, Angela
    CANCER, 2010, 116 (03) : 592 - 599
  • [2] Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer
    Sinha, N.
    Letourneau, J. M.
    Wald, K.
    Xiong, P.
    Imbar, Tal
    Li, B.
    Harris, E.
    Mok-Lin, E.
    Cedars, M. I.
    Rosen, Mitchell P.
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2018, 35 (10) : 1861 - 1868
  • [3] Antimullerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception
    Johnson, Lauren N. C.
    Sammel, Mary D.
    Dillon, Katherine E.
    Lechtenberg, Lara
    Schanne, Allison
    Gracia, Clarisa R.
    FERTILITY AND STERILITY, 2014, 102 (03) : 774 - U489
  • [4] Correlation of Follicle-stimulating Hormone, Anti-Mullerian Hormone, and Antral Follicle Count with Age in Ovarian Reserve Testing
    Das, Subrata
    Bhattacharya, Namrata
    Mahata, Ritu
    Ghosh, Sudip
    Bhar, Anindya Sundar
    Srivastava, Pragati
    INTERNATIONAL JOURNAL OF APPLIED AND BASIC MEDICAL RESEARCH, 2024, 14 (03) : 162 - 168
  • [5] Antimullerian hormone (AMH) levels and antral follicle count (AFC) as predictors of the ovarian reaction in young healthy women
    Stelcl, Marcel
    Belaskova, Silvie
    Machac, Stepan
    Fiserova, Eva
    Hubinka, Vit
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 : S50 - S53
  • [6] Assessing ovarian response: antral follicle count versus anti-Mullerian hormone
    Fleming, Richard
    Seifer, David B.
    Frattarelli, John L.
    Ruman, Jane
    REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 31 (04) : 486 - 496
  • [7] Pretreatment anti-Mullerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer
    Anderson, Richard A.
    Rosendahl, Mikkel
    Kelsey, Thomas W.
    Cameron, David A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (16) : 3404 - 3411
  • [8] Antral follicle count recovery in women with menses after treatment with and without gonadotropin-releasing hormone agonist use during chemotherapy for breast cancer
    N. Sinha
    J. M. Letourneau
    K. Wald
    P. Xiong
    Tal Imbar
    B. Li
    E. Harris
    E. Mok-Lin
    M. I. Cedars
    Mitchell P. Rosen
    Journal of Assisted Reproduction and Genetics, 2018, 35 : 1861 - 1868
  • [9] Ovarian function after chemotherapy in young breast cancer survivors
    Morarji, K.
    McArdle, O.
    Hui, K.
    Gingras-Hill, G.
    Ahmed, S.
    Greenblatt, E. M.
    Warner, E.
    Sridhar, S.
    Ali, A. M. F.
    Azad, A.
    Hodgson, D. C.
    CURRENT ONCOLOGY, 2017, 24 (06) : E494 - E502
  • [10] Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone
    Lee, Sanghoon
    Ozkavukcu, Sinan
    Heytens, Elke
    Moy, Fred
    Alappat, Rose M.
    Oktay, Kutluk
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2011, 28 (07) : 651 - 656